Genmab — November 2017
-
-
Flere udenlandske investorer kan få blod på tanden og købe ind i succesen i morgen
-
Den er nem - GSK ofa MS
-
Copenhagen, Denmark; November 17, 2017 — Genmab A/S (Nasdaq Copenhagen: GEN) announced today that it has achieved a USD 50 million sales volume milestone in its DARZALEX
(daratumumab) collaboration with Janssen Biotech, Inc. The milestone was triggered by confirmation by Janssen that sales of DARZALEX reached USD 1 billion in a calendar year. -
-
Dette store Ph lll studie ( ofatumumab-chlorambucil-bendamustine ) i CLL burde vi også snart få resultater fra.- Estimated Primary Completion Date December 2017 https://www.clinicaltrials.gov/ct2/show/NCT01678430?term=ofatumumab&recrs=ab&draw=1&rank=7
-
God morgen.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind